ERYTECH reports financial highlights for Q2 2015 Post author:admERY Post published:July 8, 2015 Post category:Newsroom ERYTECH reports cash balance and revenues for the second quarter of 2015. You Might Also Like ERYTECH Completes Patient Enrollment in Phase 2 Trial of eryaspase (GRASPA®) for Pancreatic Cancer September 26, 2016 ERYTECH to Host Second Quarter 2018 Conference Call and Bussiness Update September 6, 2018 ERYTECH to Present Results from Phase I Trial of eryaspase in ALL and New Pre-clinical Data at AACR 2018 April 12, 2018
ERYTECH Completes Patient Enrollment in Phase 2 Trial of eryaspase (GRASPA®) for Pancreatic Cancer September 26, 2016
ERYTECH to Present Results from Phase I Trial of eryaspase in ALL and New Pre-clinical Data at AACR 2018 April 12, 2018
